Transcarent To Acquire Accolade (ACCD) for $7.03 per share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)
January 8, 2025 12:07 PM ESTTruist Securities analyst Jailendra Singh reiterated a Buy rating and $7.50 price target on Accolade Inc. (NASDAQ: ACCD)
The analyst comments "Why We Like the Deal. We have long viewed mergers between digital health companies as being accretive in value proposition for end-markets as opposed to entities such as... More



